Home/Filings/4/0000950170-23-035684
4//SEC Filing

Berman Mark A. 4

Accession 0000950170-23-035684

CIK 0001832415other

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 7:59 AM ET

Size

5.0 KB

Accession

0000950170-23-035684

Insider Transaction Report

Form 4
Period: 2023-07-27
Berman Mark A.
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2023-07-27$0.73/sh+54,802$40,000388,191 total
Footnotes (2)
  • [F1]On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
  • [F2]As one of the PIPE Investors, the Reporting Person acquired 54,802 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.

Documents

1 file

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1
  • filerCIK 0001890348

Filing Metadata

Form type
4
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 7:59 AM ET
Size
5.0 KB